EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment

Dorota E Jazwinska iD, Diana G Kulawiec, Ioannis K Zervantonakis iD

American Journal of Physiology-Cell Physiology · 01.09.2023 · 325 (3) · C721-C730

DOI: 10.1152/ajpcell.00461.2022 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.09.2023. Verfasst von Dorota E Jazwinska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, United States. Hauptthemen laut MEDLINE: Tumor Microenvironment, Ovarian Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIBIB NIH HHS, Elsa U. Pardee Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The metastatic ovarian cancer microenvironment is characterized by an intricate interaction network between cancer cells and host cells. This complex heterotypic cancer-host cell crosstalk results in an environment that promotes cancer cell metastasis and treatment resistance, leading to poor patient prognosis and survival. In this review, we focus on two host cell types found in the ovarian cancer microenvironment: mesothelial cells and tumor-associated macrophages. Mesothelial cells make up the protective lining of organs in the abdominal cavity. Cancer cells attach and invade through the mesothelial monolayer to form metastatic lesions. Crosstalk between mesothelial and cancer cells can contribute to metastatic progression and chemotherapy resistance. Tumor-associated macrophages are the most abundant immune cell type in the ovarian cancer microenvironment with heterogeneous subpopulations exhibiting protumor or antitumor functions. Macrophage reprogramming toward a protumor or antitumor state can be influenced by chemotherapy and communication with cancer cells, resulting in cancer cell invasion and treatment resistance. A better understanding of cancer-mesothelial and cancer-macrophage crosstalk will uncover biomarkers of metastatic progression and therapeutic targets to restore chemotherapy sensitivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentOvarian NeoplasmsHumansFemaleCell Line, TumorEpitheliumMacrophages

Stichwörter der Autor:innen

chemotherapymacrophagemesothelialmicroenvironmentovarian cancer

Autor:innen und Institutionen

  • Department of Bioengineering and Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
  • McGowan Institute of Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.

ORCID-Profile: Dorota E Jazwinska, Ioannis K Zervantonakis

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • Elsa U. Pardee Foundation
  • HHS | NIH | National Cancer Institute
  • HHS | NIH | National Institute of Biomedical Imaging and Bioengineering
  • Magee-Womens Research Institute

Zitieren

APA

Jazwinska, D. E., Kulawiec, D. G., & Zervantonakis, I. K. (2023). Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment. American Journal of Physiology-Cell Physiology, 325(3), C721-C730. https://doi.org/10.1152/ajpcell.00461.2022

Vancouver

Jazwinska DE, Kulawiec DG, Zervantonakis IK. Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment. American Journal of Physiology-Cell Physiology. 2023;325(3):C721-C730. doi:10.1152/ajpcell.00461.2022

BibTeX
@article{Jazwinska2023,
  author = {Jazwinska, Dorota E and Kulawiec, Diana G and Zervantonakis, Ioannis K},
  title = {Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2023},
  volume = {325},
  number = {3},
  pages = {C721--C730},
  doi = {10.1152/ajpcell.00461.2022}
}
Kostenlos starten →